CoagulationDisorders near West Harrison, NY

Biography: Dr. Lyndon Kim, MD is a Hematology Specialist who practices in New York, NY. He is 71 years old and has been practicing for 40 years. Dr. Lyndon Kim, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Anna Pavlick, BSN, MSc, DO, MBA is a medical oncologist with over 20 years of experience treating patients with skin cancer, including melanoma, basal cell cancer,squamous cell cancer and Merkel cell carcinoma. She is also an expert in treating ocular melanoma, eyelid tumors and other rare solid tumor malignancies, including a research interest in neurofibromatosis-1 (NF1) malignancies. She is currently accepting new patients for both in-office visits and telehealth appointments.Dr. Pavlick was recruited to Weill Cornell Medicine as Professor of Medicine in the Division of Hematology & Medical Oncology. She is the founding Director of the Cutaneous Oncology Program at Weill Cornell Medicine and NewYork-Presbyterian. Dr. Pavlick's major research interests include investigating targeted therapies, combination therapies and immunotherapies. She also conducts outcomes research evaluating quality of life.Dr. Pavlick earned her medical degree from the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School; her Master of Science in Human Anatomy from Fairleigh Dickinson University; and her Bachelor of Science in Biology and Nursing degree from Fairfield University. She completed an internal medicine residency at UMDNJ and hematology and oncology fellowship training at Memorial Sloan Kettering Cancer Center. In addition to her undergraduate and medical training, Dr. Pavlick graduated from the Drexel School of Medicine Executive Leadership in Academic Medicine in 2012 and earned her Master of Business Administration (MBA) degree from Columbia University Business School in 2017.Dr. Pavlick has authored and co-authored over 100 publications and presented her research at international meetings. She serves on the several editorial boards, including The Journal of Drugs in Dermatology and The Journal of ImmunoTherapeutics of Cancer (Associate Editor). She is a member of leading oncology societies including American Society of Clinical Oncology (ASCO), American Academy of Clinical Research (AACR), the Society for Melanoma Research, Society for Immunotherapy and Translational Research in Cancer and the European Society of Medical Oncology (ESMO).

Biography: Dr. Iwamoto is a neuro-oncologist whose previous training includes a neurology residency at NewYork-Presbyterian/Weill Cornell Medical Center and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. For over three years, Dr. Iwamoto was an attending physician and an investigator at the Neuro-oncology Branch, a trans-institute branch of the National Cancer Institute and National Institute of Neurological Disorders and Stroke, in Bethesda, MD. At the intramural NIH, Dr. Iwamoto was a principal investigator in early phase clinical trials for brain tumors and worked with laboratory and computational scientists on several translational projects in brain tumors. Dr. Iwamoto was recruited to Columbia University as the Deputy Director of the Neuro-oncology Division and is actively developing the clinical and translational research components of this program. He is an expert in the diagnosis, management, and treatment of brain and spinal cord tumors as well as neurological complications of cancer.

Biography: James McKiernan, MD, is the John K. Lattimer Professor of Urology, and CEO, of ColumbiaDoctors. He also is the interim dean of Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues. For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

Biography: Dr. James Lee is an internationally recognized endocrine surgeon who specializes in the care of patients with thyroid, parathyroid, and adrenal disorders. Dr. Lee is the Chief of Endocrine Surgery and the Edwin K. and Anne C. Weisskopf Professor of Surgical Oncology at Columbia University and the Physician Director of the Endocrine Service Line at the NY Presbyterian Hospital. He serves as Co-Director of the multidisciplinary Columbia Thyroid Center, Parathyroid Center, and Adrenal Center. He has been rated as one of the Best Doctors in America and is one of the highest volume endocrine surgeons in the country. Dr. Lee received his medical degree from Columbia University's College of Physicians and Surgeons, completed his residency in General Surgery at Columbia and went on to a fellowship in Endocrine Surgery at the University of California, San Francisco. Dr. Lee is actively involved in the leadership of Endocrine Surgery at the national and international level. He serves on the Executive Council of the American Association of Endocrine Surgeons and Standing Faculty of the international Endocrine Surgery University. He co-created the inaugural Postgraduate Course in Endocrine Surgery at the American College of Surgeons and is a featured lecturer in the biannual Masters of Endocrine Surgery Course. He has authored over 100 articles and book chapters, including the AAES Parathyroidectomy Guidelines which sets the international standard for the care of patients with parathyroid disease. He is also the Co-Editor of Surgical Endocrinopathies and the Founding Figures which details state of the art care for patients with endocrine disorders as well as the rich history of discovery in the field. Dr. Lee has given over 100 invited lectures and visiting professorships at institutions around the world. He has travelled extensively to teach other endocrine surgeons advanced techniques such as minimally invasive thyroid and parathyroid surgery as well as laparoscopic retroperitoneal adrenalectomy. He has mentored dozens of clinical and research fellows over his career, many of whom are now leaders in their own institutions and abroad. Dr. Lee also serves as the Vice Chair of New Media in the Columbia University Department of Surgery and Chair of the ColumbiaDoctors Communications Committee. In this role, he oversees the digital strategy for multiple groups across the medical center with the mission of providing the highest quality education on health and wellness to the global audience.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Care Philosophy: Multidisciplinary, respectful care of patients with GU cancers